The Federal Reserve's policy reaction function is being pulled apart by two opposing forces that have nothing to do with the classic growth-inflation trade-off. On one side, the rapid adoption of GLP-1 weight-loss drugs is beginning to exert a measurable, structural disinflationary drag on the Consumer Price Index, particularly within the sticky services and food-at-home components. On the other, the administration's aggressive tariff posture, culminating in the abrupt cancellation of a planned strike on Iran in favor of a negotiated perimeter, is injecting a fresh, supply-side price shock into the system. The market's reflexive assumption that the Fed is on a one-way path to easing in the second half of the year is not just complacent—it is ignoring the fact that the central bank's own models are ill-equipped to parse a disinflationary demand shock from a purely political supply shock. The next 90 days will be defined not by the level of the fed funds rate, but by the Fed's ability to articulate a new framework that can hold both realities simultaneously.
The PCE Scourge: GLP-1s as the Fed's New Structural Tailwind
While the equity market has focused on the revenue boom for pharmacy benefit managers and big-box retailers from the GLP-1 prescription surge, the macro implications for the Fed's preferred inflation gauges are being severely underpriced. The mechanism is not subtle. A significant portion of the CPI basket is comprised of food-at-home and aggregate medical services. As a larger cohort of the population adopts these therapies—not just for diabetes, but for the broader obesity epidemic—caloric intake drops, leading to a measurable decline in the volume of packaged foods, snacks, and prepared meals purchased. This is not a cyclical shift in consumer preference; it is a pharmacological one.
Early data from point-of-sale terminals at Walmart and Costco suggest a shift in basket composition that is already showing up in the less-volatile "core" goods ex-housing data. More importantly, the medical services component of CPI, which has been a persistent source of sticky inflation, is seeing a subtle but real deceleration in demand for a host of obesity-related co-morbidities, from joint replacements to sleep apnea treatments. The Fed's models, which rely heavily on labor market tightness and shelter inflation, have no variable for "pharmacological demand destruction." If this trend accelerates—and with Amazon entering the direct-to-consumer prescription market, it will—the Fed could see a surprise softening in core PCE in Q3 that has nothing to do with restrictive policy and everything to do with the composition of the American waistline.
This creates a dangerous analytical trap for the FOMC. If they see inflation running below target in the autumn, they will be tempted to declare victory and cut rates, assuming their policy stance is doing the heavy lifting. In reality, the disinflation is a supply-side, non-monetary phenomenon. Cutting rates into a GLP-1-driven disinflationary impulse could overstimulate an economy that is not actually weak, reigniting the very housing and durable goods demand they just spent two years suppressing.
The Perimeters of a Deal: Tariffs as the Supply-Side Counterweight
Simultaneously, the geopolitical landscape has shifted from kinetic risk to economic risk. The cancellation of the planned strike on Iran, replaced by a negotiated agreement over "perimeters," is a market-positive development in the short term, as it removes the immediate tail-risk of a Strait of Hormuz closure. However, the deal-making posture that led to this outcome is the same tactical playbook being used in the trade arena. The administration views tariffs not as a negotiating tool to be deployed and removed, but as a permanent revenue-generating and reshoring mechanism. The "perimeters of a deal" language suggests a framework of managed tension, not a return to free trade.
This is where the policy reaction function becomes muddled. The GLP-1 disinflation is a slow, grinding force. The tariff shock is a sharp, immediate one. A 10% universal baseline tariff, or even sector-specific tariffs on electronics and autos, hits the CPI within two to three months. The recent spike in EV prices, which are not following the "law of used cars" due to battery material tariffs and domestic content requirements, is a microcosm of this. These are not one-off price level shifts; they are recurring monthly contributions to inflation as new tariff schedules are layered onto the import pipeline.
The Fed is facing a scenario where the year-over-year headline number could look beautifully controlled—thanks to the GLP-1 effect on food and medical costs—while the quarter-over-quarter annualized rate of core inflation accelerates due to tariff pass-through. The market will seize on the year-over-year data to price in cuts, while the Fed's internal forecasts will be screaming that the sequential momentum is heading in the wrong direction.
The DXY and the Real Yield Conundrum
This divergence has direct implications for the dollar and the long end of the curve. If the market perceives the Fed is about to cut into a tariff-induced inflation spike, the term premium on the 10-year Treasury will rise sharply. The real yield, which is the true driver of global asset allocation, is currently being supported by a mix of QT and a robust economy. A policy error here—cutting for the wrong reason—would force the market to reprice the terminal rate higher, not lower.
We are entering a phase where the DXY is no longer a simple reflection of rate differentials. It is becoming a barometer of the Fed's credibility. If the committee allows the GLP-1 data to lull them into a false sense of security, the dollar could weaken sharply against a basket of currencies whose central banks are not making the same mistake. The yen, in particular, could see a violent repricing if the BOJ normalizes policy while the Fed cuts, creating a carry-trade unwind that would tighten global financial conditions far more than any 25bp cut would loosen them.
Scenarios and Market Positioning
We see three distinct pathways emerging from this data fog.
- The Muddle-Through (40% probability): The Fed holds rates steady through September, citing "elevated uncertainty," allowing the tariff shock to pass through the index without a policy response. The GLP-1 disinflation keeps the headline low enough to avoid a political backlash. Real yields stay range-bound, and the S&P 500 grinds higher on AI earnings, but with a volatility profile that punishes leveraged beta.
- The Preemptive Cut (35% probability): The labor market cracks in August, pushing the Fed to cut despite the tariff headwinds. This is the "stagflationary easing" scenario. It would be acutely negative for the dollar, positive for gold, and would steepen the yield curve aggressively as inflation breakevens rise faster than nominal yields.
- The Hawkish Surprise (25% probability): The sequential inflation data from tariffs proves more stubborn than expected, forcing the Fed to signal that a hike is not off the table. This would be a violent shock to equity valuations, particularly in the long-duration tech complex, and would send the DXY surging past recent highs.
Risk and the Path Forward
The primary risk to this analysis is that the GLP-1 effect is overestimated and the tariff effect is underestimated, leading to a straightforward re-acceleration of inflation that forces a hawkish pivot. Conversely, if the "perimeters of a deal" extends to a broader trade truce with China, the supply-side shock could be muted, allowing the Fed to ease without consequence.
The bottom line is that the market is trading a linear path to lower rates, but the data is offering a non-linear constellation of inputs. The Fed's reaction function is no longer a simple Taylor rule calculation; it is a political and pharmacological guessing game. The prudent positioning is to fade the front-end rate cut expectations and own duration through the belly of the curve, while maintaining a long gold position as a hedge against the policy error risk inherent in this environment. The next FOMC meeting will be less about the dot plot and more about the narrative—and the narrative is fragmented.
This material is provided for informational purposes only and does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any financial instrument. Past performance is not indicative of future results. Markets involve substantial risk, and you should consult with a qualified financial professional before making any investment decisions.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.